Skip to main content
Contact Us
Subscribe
E-Edition
85°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Bristol/Myers Squibb Co
Recent news which mentions Bristol/Myers Squibb Co
< Previous
1
2
3
Next >
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
April 01, 2025
Tags
Merck & Co Inc
LILLY DRN
Biogen Inc
From
CNBC.com News
Cramer's Lightning Round: Deere is a buy
February 19, 2025
Tags
Stock Picks
Investment strategy
Investment Strategy
From
CNBC.com News
Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
February 10, 2025
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Government and politics
From
CNBC.com News
5 things to know before the stock market opens Thursday
February 06, 2025
Tags
Peloton Interactive Inc
Business
Yum! Brands Inc
From
CNBC.com News
Bristol Myers Squibb plans $2 billion in cost cuts by 2027, issues weak guidance
February 06, 2025
Tags
Biotech and Pharmaceuticals
Business
Health & Science
From
CNBC.com News
5 things to know before the stock market opens Monday
February 03, 2025
Tags
Ford Motor Co
Walt Disney Co
Markets
From
CNBC.com News
Jim Cramer's week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir
January 31, 2025
Tags
Palantir Technologies Inc
stocks
Chipotle Mexican Grill Inc
From
CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
January 17, 2025
Tags
GSK plc
AstraZeneca PLC
Health & Science
From
CNBC.com News
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
January 15, 2025
Tags
US: News
Biogen Inc
Biotechnology
From
CNBC.com News
Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals
January 14, 2025
Tags
Waystar Holding Corp
Teladoc Health Inc
Amgen Inc
From
CNBC.com News
Bristol Myers Squibb CEO describes new drug for treating schizophrenia
January 13, 2025
Tags
stocks
Business
Investment Strategy
From
CNBC.com News
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market
January 08, 2025
Tags
Iovance Biotherapeutics Inc
Merck & Co Inc
LILLY DRN
From
CNBC.com News
Here are our top 10 things to watch in the stock market Monday
December 23, 2024
Tags
Nissan Motor Co Ltd
CNBC Investing Club
CNBC Investing Club: Analysis
From
CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
December 05, 2024
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
AstraZeneca PLC
From
CNBC.com News
Cramer says an RFK Jr.-run HHS ultimately won't tank junk food and drug industries
November 15, 2024
Tags
Business News
LILLY DRN
PepsiCo Inc/
From
CNBC.com News
Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs
October 31, 2024
Tags
Health care industry
Bristol/Myers Squibb Co
Pharmaceuticals
From
CNBC.com News
5 things to know before the stock market opens Monday
October 28, 2024
Tags
Business News
Merck & Co Inc
Starbucks Corp
From
CNBC.com News
Cramer’s week ahead: Earnings from Alphabet, Meta, Apple, Microsoft and Amazon
October 25, 2024
Tags
Advanced Micro Devices Inc
Microsoft Corp
Investment strategy
From
CNBC.com News
5 things to know before the stock market opens Friday
September 27, 2024
Tags
Business News
Meta Platforms Inc
Investing
From
CNBC.com News
FDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in decades
September 26, 2024
Tags
Health & Science
Business
Breaking news
From
CNBC.com News
Drugmakers bet billions that targeted radiation could become the next cancer breakthrough
September 16, 2024
Tags
Biotech and Pharmaceuticals
Health & Science
Eli Lilly and Co
From
CNBC.com News
What's next for the Biden administration's Medicare drug price negotiations
August 15, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Social issues
From
CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
August 15, 2024
Tags
Abbvie Inc
Breaking news
Biotech and Pharmaceuticals
From
CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
August 06, 2024
Tags
Health care industry
Bristol/Myers Squibb Co
Politics
From
CNBC.com News
Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costs
July 26, 2024
Tags
FactSet Research Systems Inc
Biotech and Pharmaceuticals
Breaking news
From
CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
July 23, 2024
Tags
Johnson & Johnson
Novartis AG
Health & Science
From
CNBC.com News
5 things to know before the stock market opens Monday
July 22, 2024
Tags
Coca/Cola Co
Comcast Corp
General Motors Co
From
CNBC.com News
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
June 28, 2024
Tags
Biotechnology
Business News
US: News
From
CNBC.com News
Cramer's Lightning Round: 'I would not abandon' Cava
June 24, 2024
Tags
Stock Picks
Forward Air Corp
Investment strategy
From
CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
June 07, 2024
Tags
Pfizer Inc
Johnson & Johnson
Health & Science
From
CNBC.com News
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.